CEO Interviews

Alnylam CEO on what is next for heart disease drug

CNBC's Angelica Peebles and Yvonne Greenstreet, Alnylam CEO, joins 'Fast Money' to talk the companies latest heart condition drug data and what the path to approval looks like.

adminadmin
Jun 25, 2024 - 10:00
 0  6
Alnylam CEO on what is next for heart disease drug
CNBC's Angelica Peebles and Yvonne Greenstreet, Alnylam CEO, joins 'Fast Money' to talk the companies latest heart condition drug data and what the path to approval looks like.
Read More

Tags:

Previous Article

Housing in pandemic boom towns up to 40% overvalued, says Reventure CEO Nick Gerli

Next Article

Recursion CEO Chris Gibson talks integrating AI into drug development process

admin
admin

Related Posts

Republic Services CEO on waste management demand, electrification push and impact of AI

Republic Services CEO on waste management demand, elect...

admin Oct 16, 2024  0  9

Valley Bank CEO on the health of banks, rate cut optimism and bank lending

Valley Bank CEO on the health of banks, rate cut optimi...

admin Aug 14, 2024  0  5

Philip Morris CEO weighs in on Q3 results

Philip Morris CEO weighs in on Q3 results

admin Oct 23, 2024  0  9